May 13, 2026 01:00AM

Mar 26, 2026 02:00AM

Nov 13, 2025 01:00AM

Nov 10, 2025 01:01AM

Nov 10, 2025 01:00AM

Oct 14, 2025 01:00AM

Sep 17, 2025 01:00AM Innate Pharma Reports First Half 2025 Business Update and Financial Results

May 23, 2025 01:00AM

May 13, 2025 01:00AM

Apr 16, 2025 01:00AM

Mar 27, 2025 02:00AM

Feb 17, 2025 01:02AM

Jan 21, 2025 01:00AM

Dec 9, 2024 01:00AM Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma

Dec 3, 2024 01:00AM

Nov 13, 2024 01:00AM

Sep 23, 2024 01:00AM

Sep 12, 2024 01:00AM

Jun 17, 2024 01:00AM

Jun 4, 2024 01:00AM

May 21, 2024 01:00AM Innate Pharma: Clarification Regarding SAR443579 Designation

May 14, 2024 01:00AM

Apr 15, 2024 01:00AM

Mar 21, 2024 02:00AM

Jan 4, 2024 01:00AM

Dec 11, 2023 01:00AM

Dec 10, 2023 01:00AM

Nov 27, 2023 01:00AM Innate Pharma to Host Virtual KOL Event on Lacutamab

Nov 14, 2023 01:00AM

Oct 5, 2023 01:00AM

Sep 22, 2023 01:00AM

Sep 14, 2023 01:00AM

Jun 16, 2023 01:00AM

Jun 12, 2023 01:00AM

Jun 8, 2023 01:00AM SAR’579 / IPH6101 Receives FDA Fast Track Designation in the US for the Treatment of Hematological Malignancies

Jun 8, 2023 01:00AM

Dec 10, 2022 10:00AM

Nov 4, 2022 02:00AM

Mar 18, 2021 02:00AM

Dec 11, 2020 01:00AM

Dec 3, 2020 08:30AM

Dec 2, 2020 01:00AM Innate Pharma 2021 Financial Calendar

Nov 17, 2020 01:00AM

Nov 13, 2020 01:00AM

Nov 12, 2020 01:00AM

Oct 23, 2020 01:00AM

Oct 13, 2020 01:00AM

Sep 8, 2020 01:00AM

Sep 4, 2020 01:00AM Upcoming Investor Conferences

Aug 11, 2020 01:00AM

322,938 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All